Form D · Biotechnology

Petra Pharma Corp

New York, NY · CIK 0001662118

Offering snapshot reported Mar 31, 2020 · SEC filing

Reported sold
$27.5M
Offering amount: $27.5M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 30, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$13.8M$27.5MSep 13, 2018: $10,000,005.00Sep 13, 2018Apr 26, 2019: $13,343,020.00Apr 26, 2019Aug 1, 2019: $17,045,484.00Aug 1, 2019Oct 21, 2019: $20,045,484.00Mar 31, 2020: $27,545,484.00Mar 31, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,045,484 → $27,545,484

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 31, 2020Amendment$27,545,484$7,500,000vs Oct 21, 201910SEC filing
Oct 21, 2019Amendment$20,045,484$3,000,000vs Aug 1, 201910SEC filing
Aug 1, 2019Amendment$17,045,484$3,702,464vs Apr 26, 201910SEC filing
Apr 26, 2019Amendment$13,343,020$3,343,015vs Sep 13, 201810SEC filing
Sep 13, 2018Initial$10,000,005No comparison9SEC filing
Jan 22, 2018Amendment$31,204,516$10,000,005vs Jan 4, 201713SEC filing
Jan 4, 2017Amendment$21,204,511$11,212,311vs Jan 6, 201611SEC filing
Jan 6, 2016Initial$9,992,200No comparison12SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-321233

Source: Form D, filed Mar 31, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Barbara Dalton Director
M. Johnston Erwin Director
Jenna Foger Director
Steve Gillis Director
Thong Le Director, Promoter
Joel Marcus Director
David Mc Elligott Executive, Promoter
Brian O'callaghan Director, Executive
Lindsay Rayle Promoter
David Renas Executive
David Schubert Promoter
Paul Sekhri Director
James Sullivan Director
Misti Ushio Director
Asish Xavier Director
Albert Yu Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
450 E 29th St., Suite 506
New York, NY, 10016